Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
205.44
-3.14 (-1.51%)
At close: Dec 5, 2025, 4:00 PM EST
206.00
+0.56 (0.27%)
After-hours: Dec 5, 2025, 5:55 PM EST
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $12.55 billion as of December 5, 2025. Its market cap has increased by 78.82% in one year.
Market Cap
12.55B
Enterprise Value
12.87B
1-Year Change
78.82%
Ranking
Category
Stock Price
$205.44
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $12.55B, an increase of 2,696.79%. That is a compound annual growth rate of 35.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 12.74B | 60.89% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |